St. Louis, MO 的 脂肪性肝病 臨床試驗
9 項針對 脂肪性肝病 的研究正在 St. Louis（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
招募中3 期
- 89bio Clinical Study Site, St Louis
- 89bio Clinical Study Site, St Louis
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
招募中3 期
- 89bio Clinical Study Site, St Louis
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
招募中3 期
- GSK Investigational Site, St Louis
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
招募中3 期
- GSK Investigational Site, St Louis
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
招募中2 期
- Washington University School of Medicine, St Louis
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
招募中3 期
- Akero Clinical Study Site, St Louis
- Akero Clinical Study Site, St Louis
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
招募中3 期
- GSK Investigational Site, St Louis
- GSK Investigational Site, St Louis
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
招募中2 期
- Gateway GI Research, LLC, St Louis
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
招募中3 期
- GSK Investigational Site, St Louis
其他城市的 脂肪性肝病 試驗
- San Antonio, TX17 項研究
- Miami, FL16 項研究
- New York City, NY16 項研究
- San Diego, CA14 項研究
- Austin, TX13 項研究
- Houston, TX13 項研究
- Richmond, VA12 項研究
- Tucson, AZ10 項研究
- Chandler, AZ10 項研究
- Orlando, FL9 項研究
- Dallas, TX9 項研究
- Hialeah, FL9 項研究
St. Louis 的其他研究
- 非小細胞肺癌73 項研究
- 乳癌64 項研究
- 轉移性癌症54 項研究
- 大腸直腸癌50 項研究
- 癌症（所有類型）46 項研究
- 前列腺癌46 項研究
- 肺癌39 項研究
- 卵巢癌38 項研究
- 胰臟癌33 項研究
- 子宮內膜癌29 項研究
- 頭頸部鱗狀細胞癌28 項研究
- 心臟衰竭26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。